OBJECTIVES: Upon completion of this activity, the participant should be able to:(1) Describe the evolution of TAVR from only in the high/extreme risk to low risk population, (2) SAVR vs TAVR when, whom and why, (3) Review the guidelines for TAVR in aortic stenosis.
FACULTY DISCLOSURE: Sukesh Burjonroppa, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
PLANNERS DISCLOSURES: Sukesh Burjonroppa and Jay Herd, MD do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information please contact Mary Biggers at Mary.Biggers@BSWHealth.org
- 1.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance